Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02490800
Title Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Basilea Pharmaceutica
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | DEU | CHE | BEL


No variant requirements are available.